SAN DIEGO, CA -- (Marketwire) -- 09/14/10 -- SpectraScience, Inc. (OTCBB: SCIE), a San Diego based medical device company, today announced that an independent study performed at the San Diego Veterans Administration Hospital on 383 patients markedly reduced the cost of care when using the Company's WavSTAT Optical Biopsy System in screening for colorectal cancer. In a managed care environment, the projected savings for a similar number of patients was estimated to exceed $15,000. The study essentially described how fewer, more targeted, physical biopsies taken as a result of the ability to isolate diseased tissue with the WavSTAT Optical
More...
More...